Skip to main content
ALT logo
ALT
(NASDAQ)
Altimmune, Inc.
$3.36-- (--)
Loading... - Market loading

Altimmune (ALT) Stock Price & Financial Analysis

Altimmune Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.34 - $3.55
52-Week High$6.44
52-Week Low$2.56
Open$3.46
Volume3.59M
Average Volume (3M)4.92M
Market Cap425.66M
Shares Outstanding124.46M
Price to Sales (P/S)11823.87
Price to Book (P/B)1.50
EV/EBITDA-4.07
Revenue (TTM)36.00K
Net Income (TTM)-91.08M
Free Cash Flow (TTM)-71.97M
EPS (TTM)$-0.92
Profit Margin-253002.78%
Operating Margin-269216.67%
Return on Equity (ROE)-32.07%
Debt to Equity0.13
50-Day MA$3.03
200-Day MA$3.64
52-Week Change-9.43%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateFeb 6, 2017

Frequently Asked Questions About Altimmune

What is the current stock price for ALT?

As of the latest trading session, ALT stock trades at $3.36. The 52-week range is $2.56–$6.44, with a day range of $3.34–$3.55.

What is the P/E ratio for ALT?

The P/E ratio (Price-to-Earnings) for ALT is shown in the Key Statistics section. This valuation metric helps compare Altimmune, Inc. to industry peers.

Does ALT pay dividends?

Altimmune does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALT?

Based on 7 analysts, the consensus for ALT is Buy.

What is the market cap of ALT?

Altimmune's market capitalization is $418.2M, classifying it as a small-cap company. Altimmune operates in the Healthcare sector within the Biotechnology industry.